[

bharat biotech international limited

]

Brazil’s top court okays graft probe against Bolsonaro in Covid-19 vaccine deal

President Jair Bolsnaro has been accused of ‘irregularities’ in a deal with India’s Bharat Biotech for 20 million doses of its anti Covid-19 shot, Covaxin.
Brazil president Jair Bolsonaro (File Photo/Reuters)
Brazil president Jair Bolsonaro (File Photo/Reuters)
Updated on Jul 03, 2021 08:27 PM IST
Copy Link
Byhindustantimes.com | Written by Karan Manral, New Delhi

Covaxin 'effectively neutralises' Alpha, Delta Covid-19 variants, says US NIH

According to NIH, the US' primary health agency, the observation is based on results of two studies of blood serum from people who received a Covaxin shot.
The Covaxin anti-Covid vaccine (Sanchit Khanna/HT PHOTO)
The Covaxin anti-Covid vaccine (Sanchit Khanna/HT PHOTO)
Published on Jun 30, 2021 06:56 AM IST
Copy Link
Byhindustantimes.com | Written by Karan Manral | Edited by Amit Chaturvedi, New Delhi

Covaxin likely to be approved for children by Sept: Dr Randeep Guleria

AIIMS director Dr Randeep Guleria said data Covaxin’s phase 2 and 3 trials for children would be made available by September, adding that the vaccine itself could be approved in the same month.
Covaxin likely to be approved for children by September, says Dr Randeep Guleria (PTI Image/Used for representative purpose only)
Covaxin likely to be approved for children by September, says Dr Randeep Guleria (PTI Image/Used for representative purpose only)
Updated on Jun 23, 2021 10:27 AM IST
Copy Link
Byhindustantimes.com | Written by Karan Manral | Edited by Amit Chaturvedi, New Delhi

Bharat Biotech confident of Covaxin making it to WHO EUL: Sources

  • Bharat Biotech is also in the final stages of submission of documents for regulatory approval of Covaxin in Brazil and Hungary, who are reportedly confident about the efficacy of the vaccine
Bharat Biotech held a meeting with government officials to discuss the EUL listing of Covaxin, REUTERS/Stringer/Files(REUTERS)
Bharat Biotech held a meeting with government officials to discuss the EUL listing of Covaxin, REUTERS/Stringer/Files(REUTERS)
Updated on May 24, 2021 08:42 PM IST
Copy Link
Byhindustantimes.com | Edited by Ayshee Bhaduri, Hindustan Times, New Delhi

Nitin Gadkari says he was 'unaware', a day after his vaccine ramp-up suggestions

Nitin Gadkari on Tuesday said the government should give licences to more companies to manufacture vaccines, a proposal made by many opposition leaders earlier. The Centre has also given permission to 3 PSUs to manufacture Bharat Biotech's Covaxin.
Union minister Nitin Gadkari on Wednesday said he is glad that the ministry concerned has already started working towards granting licence to more companies to manufacture vaccines. (PTI)
Union minister Nitin Gadkari on Wednesday said he is glad that the ministry concerned has already started working towards granting licence to more companies to manufacture vaccines. (PTI)
Published on May 19, 2021 02:55 PM IST
Copy Link
Byhindustantimes.com | Edited by Poulomi Ghosh

Bharat Biotech gets nod to conduct Covaxin trial through skin

Currently, the vaccine was being tested through intramuscular route, where it is injected directly into the muscle. The trial is being run on 1,125 patients at 12 hospitals across the country including All India Institute of Medical Sciences.
The CDSCO is a pharmaceutical regulatory body under the health ministry. It regulates the quality of drugs and vaccines in the country.(Reuters file photo for representation)
The CDSCO is a pharmaceutical regulatory body under the health ministry. It regulates the quality of drugs and vaccines in the country.(Reuters file photo for representation)
Updated on Aug 22, 2020 10:00 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Shivani Kumar
SHARE
Story Saved
×
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Sunday, November 28, 2021